Esophageal motility disorders are sometimes a consequence of systemic diseases such as scleroderma, Raynaud's disease, and systemic lupus erythematosus. When patients with these diseases have gastroparesis, which medication should be added to the regimen?
A. A proton pump inhibitor B. A histamine 2 receptor antagonist C. A calcium channel antagonist D. A promotility agent
Correct answer is:... View the full answer